| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |